ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $379,345,000 | -30.0% | 9,385,080 | -0.4% | 0.45% | -20.8% |
| Q2 2015 | $542,294,000 | -11.2% | 9,423,002 | -1.7% | 0.57% | -9.6% |
| Q1 2015 | $610,351,000 | +9.4% | 9,586,157 | +6.1% | 0.63% | +8.0% |
| Q4 2014 | $557,791,000 | +59.8% | 9,034,520 | +0.5% | 0.59% | +52.9% |
| Q3 2014 | $349,033,000 | +23.0% | 8,988,756 | +9.1% | 0.38% | +20.4% |
| Q2 2014 | $283,846,000 | -10.6% | 8,239,358 | +12.2% | 0.32% | -15.4% |
| Q1 2014 | $317,346,000 | +10.7% | 7,344,262 | +2.0% | 0.38% | +5.6% |
| Q4 2013 | $286,755,000 | +5.9% | 7,197,661 | -0.2% | 0.36% | -5.6% |
| Q3 2013 | $270,872,000 | +47.8% | 7,215,568 | +5.8% | 0.38% | +35.0% |
| Q2 2013 | $183,322,000 | – | 6,822,525 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |